AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 156 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,028 | +74.8% | 243,600 | +28.5% | 0.05% | +84.6% |
| Q2 2023 | $588 | +58.5% | 189,560 | -29.0% | 0.03% | +44.4% |
| Q1 2023 | $371 | -43.6% | 266,802 | -19.3% | 0.02% | -50.0% |
| Q4 2022 | $658 | -99.9% | 330,458 | +50.3% | 0.04% | +33.3% |
| Q3 2022 | $444,000 | -41.1% | 219,868 | -7.3% | 0.03% | -52.6% |
| Q2 2022 | $754,000 | -38.1% | 237,161 | -18.8% | 0.06% | -28.8% |
| Q1 2022 | $1,218,000 | +151.1% | 292,059 | +188.6% | 0.08% | +31.1% |
| Q4 2021 | $485,000 | -51.9% | 101,193 | -46.5% | 0.06% | -54.5% |
| Q3 2021 | $1,009,000 | +91.5% | 189,037 | +83.8% | 0.13% | -24.3% |
| Q2 2021 | $527,000 | +66.8% | 102,860 | +118.9% | 0.18% | +75.2% |
| Q1 2021 | $316,000 | -49.2% | 46,990 | -63.6% | 0.10% | -45.7% |
| Q4 2019 | $622,000 | +232.6% | 129,020 | +100.4% | 0.19% | +165.7% |
| Q3 2019 | $187,000 | – | 64,390 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $83,503,000 | 7.34% |
| Eversept Partners, LP | 2,656,208 | $10,306,087 | 2.29% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $62,908,000 | 1.13% |
| Prosight Management, LP | 512,659 | $1,989,000 | 0.95% |
| THB ASSET MANAGEMENT | 833,104 | $3,232,000 | 0.90% |
| GLOBEFLEX CAPITAL L P | 251,696 | $977,000 | 0.26% |
| XTX MARKETS LLC | 10,243 | $40,000 | 0.19% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 102,000 | $396,000 | 0.10% |
| PA Capital LLC | 33,874 | $132,000 | 0.09% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 60,900 | $236,000 | 0.07% |